Who Should Not Take Mounjaro?

Mounjaro isn’t right for everyone, and a few groups should avoid it outright. People with a history of medullary thyroid cancer or MEN2 syndrome, those who are pregnant or breastfeeding, and anyone with severe gastrointestinal disease fall into that list. For several others it isn’t a flat no, but a “not without caution,” which is exactly why a proper assessment matters before starting.

According to Dr Harikiran Chekuri, one of India’s pioneering plastic surgeon, “Most people focus on whether Mounjaro works, but the more important question early on is whether it’s safe for that specific patient. A handful of conditions make it genuinely unsuitable. Screening for those before the first dose is not optional, it’s the whole point of a medical consultation.”

For a few groups the answer is a clear no, because the risk outweighs any benefit. These are the contraindications a doctor screens for before writing a single prescription.

• Thyroid cancer history: Anyone with a personal or family history of medullary thyroid cancer should avoid it, since animal studies flagged a thyroid tumour risk.
• MEN2 syndrome: People with multiple endocrine neoplasia type 2 fall in the same category, and the drug is contraindicated for them outright.
• Pregnancy or breastfeeding: It isn’t considered safe during pregnancy or while nursing, so it’s avoided through both and usually paused well before conception.
• Pancreatitis history: A past episode of pancreatitis raises the stakes considerably, and most doctors will steer clear or proceed only with real caution.
• Severe allergy: Anyone who has reacted badly to tirzepatide or its ingredients shouldn’t take it again, as the reaction can be serious.

These aren’t grey areas, they’re firm lines. For patients in Hyderabad, Redefine Hair Transplant and Plastic Surgery Center screens for every one of them before any treatment is offered.

Then there’s a second group where it isn’t off the table, but it needs closer monitoring and an honest conversation first. The decision here really depends on the individual.

• Type 1 diabetes: It isn’t intended for type 1, so using it means careful specialist oversight rather than a routine prescription.
• Gastrointestinal disease: Conditions like severe gastroparesis can be worsened by the way the drug slows digestion, so caution is essential.
• Kidney problems: Dehydration from early nausea or vomiting can strain the kidneys, which matters more for anyone with existing kidney issues.
• Diabetic retinopathy: Rapid blood sugar changes can affect the eyes, so patients with retinopathy need monitoring alongside treatment.
• Other medications: Some drugs, insulin among them, interact with Mounjaro, which is why a full medication review comes before starting.

The point of all this is simple: the right answer comes from a proper review, not a guess. Read about peptides for weight loss to understand how these medications are assessed within a supervised programme.

Dr. Harikiran Chekuri is one of India’s pioneering surgeons in hair transplant, and he runs peptide therapy and medical weight management as a screened, assessment-led protocol rather than a prescription handed out without proper checks.

At Redefine Hair Transplant and Plastic Surgery Center, every patient goes through a full medical history and contraindication screening before treatment, so the people for whom it isn’t safe are identified before they ever start.